⚡ LATEST
Trump HHS Backs Medicaid Cut for Youth Gender Care

Trump HHS Backs Medicaid Cut for Youth Gender Care

Trump HHS official Brian Christine says the new Medicaid and CHIP rule on youth gender care protects children from irreversible harm.

The Trump administration is moving to block Medicaid and the Children’s Health Insurance Program from paying for puberty blockers, hormone therapy and surgeries for minors with gender dysphoria, and a top Health and Human Services official says the policy is meant to protect children from lasting harm. Assistant Secretary of Health and Human Services Adm. Brian Christine backed the change on Tuesday, calling for mental health counseling and compassionate care instead of medical interventions for minors.

Christine, a urologist who oversees public health offices and programs within HHS and leads the U.S. Public Health Service Commissioned Corps, said gender dysphoria is a real condition but argued that the diagnosis has expanded far beyond what he described as its historical pattern. He told Fox News Digital that the condition once affected only a small percentage of children and said the rise in diagnoses is not explained by simple epidemiology. He also said most minors diagnosed with gender dysphoria move beyond it when they receive competent, compassionate counseling.

The new rule does not outlaw the procedures outright. Instead, it ends federal financial support through Medicaid and CHIP for pediatric gender treatments. Christine said that approach reflects what he sees as the best available medical path for minors. He described hormone blockers, cross-sex hormones and surgeries as treatments that can permanently alter a young person’s body and lead to life-long complications. He said the preferred response is “corrective care,” a term he used to distinguish his view from what supporters call gender-affirming care.

Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz said in a Tuesday statement that the administration is following the science, saving taxpayer dollars and protecting children from potentially irreversible harm. President Donald Trump also weighed in on Truth Social, calling gender transition surgeries and hormones for minors “barbaric.” He said the federal government will not pay for what he described as harmful procedures on children.

Christine pushed back on the language used by supporters of youth gender treatment, saying that “mutilating surgeries” and “castrating chemicals” do not affirm anything. He argued that the science supports mental health care and counseling, not medical treatment for minors. He also said the issue has been taken over by ideology and pointed to a sharp increase in diagnoses among minors, especially young girls, as evidence of a broader social trend rather than a purely medical one.

The policy takes effect on Oct. 13. According to the rule, children already receiving hormone blockers and similar drugs will not be cut off suddenly. CMS said federal funding will remain available for a six-month tapering period for children currently on hormone therapy. That detail puts the administration’s move in line with a broader effort to phase out public support for transition-related care while avoiding an abrupt disruption for those already in treatment.

The fight over youth gender care has been building for years as states, hospitals and courts have clashed over how to treat minors diagnosed with gender dysphoria. KFF, a health policy group, says 27 states have enacted restrictions on gender-affirming care for minors. At the same time, some hospitals and courts have continued to defend access to treatment, including a Colorado Supreme Court order requiring a children’s hospital to resume gender transition treatments for minors. The new federal funding rule adds another major layer to that national battle.

For American families, insurers and state health programs, the issue now turns on access and payment. The procedures will still exist, but the loss of Medicaid and CHIP funding could change who can afford them and where they are offered. What happens next will depend on how hospitals, states and federal agencies adapt as the Oct. 13 deadline approaches. The bottom line for readers is simple: Washington is drawing a harder line on youth gender procedures, and the fight over who pays will shape the next phase of the debate.

Frequently asked questions

What does the new rule change?
It bars Medicaid and CHIP from paying for puberty blockers, hormone therapy and surgeries for minors treated for Gender Dysphoria. The procedures are not banned outright.
Who backed the policy change?
Assistant Secretary of Health and Human Services Adm. Brian Christine supported it, and CMS Administrator Dr. Mehmet Oz said it follows the science and protects children.
When does the rule take effect?
The rule takes effect on Oct. 13.
What happens to children already on hormone therapy?
CMS said federal funding will remain available for a six-month tapering period rather than forcing an abrupt stop.
Full coverage: Donald Trump
Trump, Abbott Split on Texas Data Center Boom
Up Next · in Politics

Trump, Abbott Split on Texas Data Center Boom

4 min read Continue reading

More from Politics

View all →
🇺🇸

The Defender Morning Brief

5 stories Americans need to know. 3 minutes. Every morning. Free.